封面
市场调查报告书
商品编码
1427182

全球眼保健补充品市场规模、份额、成长分析(按成分类型、适应症、剂型)- 2023-2030 年产业预测

Global Eye Health Supplements Market Size, Share, Growth Analysis, By Ingredient Type(Lutein and Zeaxanthin, Antioxidants), By Indication(Age-related Macular Degeneration (AMD), Cataract), By Formulation(Tablets, Capsules)-Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球眼保健补充品市场规模预估为17.9亿美元,从2023年的19亿美元成长到2031年的30亿美元,预测期间(2024-2031年)复合年增长率为5.9%。成长为美元。

眼保健产品市场正在经历各种因素的显着增长,例如视力障碍和近视患病率的增加,以及由于萤幕使用和线上互动(尤其是在家工作时)增加而导致的 COVID-19 爆发。近视度数的快速增加与白内障、青光眼和老龄化黄斑部病变等进行性眼科疾病的风险增加有关。这一趋势导致容易受到数位眼疲劳和近视影响的老年人和千禧世代对眼保健产品的需求不断增长,从而促进了全球市场的扩张。各种眼科疾病的流行,如老龄化黄斑部病变(AMD)、干眼症、白内障和发炎,以及眼科医生建议使用眼部保健补充品来预防和治疗这些疾病,正在推动市场的增长,我们正在进一步推动。世界卫生组织 (WHO) 报告称,全球约有 22 亿人患有视力丧失或失明,低收入和中等收入国家的盛行率明显高于高所得国家。尤其是在贫穷国家,女性更容易患上白内障和AMD等眼科疾病。美国、加拿大、澳洲和英国等新兴国家在包括眼部保健补充食品在内的医疗保健品上的人均支出较高,有助于市场扩张。对含有叶黄素和玉米黄质以及越橘萃取物以促进眼睛健康的补充品的需求不断增长,加上透过直销和电子商务平台轻鬆获得,进一步推动了市场成长。此外,旨在满足全球 10 亿未经治疗的视障残障人士需求的新型眼保健补充品的推出预计将为市场注入活力。例如,博士伦于2020年在美国推出了PreserVision AREDS 2 Formula微凝胶眼科维生素,与该公司传统的软胶囊配方相比,为晚期AMD患者提供了更方便的选择。这些补充品强大的销售管道和供应网络也为市场扩张做出了重大贡献。 NutraIngredients 的研究显示,近几个月来,眼保健补充品的网路零售大幅成长约 48.3%,而新冠肺炎 (COVID-19) 危机是造成这种成长的原因之一。这凸显了市场的弹性和适应性,为不久的将来的进一步成长铺平了道路。

自上而下和自下而上的方法已用于估计和检验全球眼保健补充品市场规模,并估计其他各个相关子市场的规模。用于估计市场规模的调查方法包括以下细节:透过二次研究确定市场的主要企业,并透过初步和二次研究确定每个地区的市场占有率。整个过程包括研究主要企业的年度报告和财务报告,以及广泛的采访,以获取首席执行官、副总裁、董事和营销负责人等行业领导者的关键见解。马苏。所有股份比率和细分均使用二手资讯确定并使用主要资讯检验。对本研究涵盖的所有可能影响市场的参数进行了解释,查看了广泛的详细资讯,并通过初步研究检验和分析,以获得最终的定量和定性资料。

眼保健补充品全球市场区隔分析

全球眼保健补充品市场按成分类型、适应症、配方和地区细分。根据成分类型,市场分为叶黄素和玉米黄质、抗氧化剂、 Omega-3脂肪酸、Coenzyme Q10、类黄酮、α-硫辛酸、虾青素和其他补充品。根据迹象,市场分为老龄化黄斑部病变(AMD)、白内障、干眼症、发炎等。依配方划分,市场分为锭剂、胶囊、粉末、软胶囊和液体。按地区划分,全球眼保健补充品市场分为北美、欧洲、亚太地区、南美洲和中东和非洲。

眼保健补充品的全球市场驱动因素

老龄化黄斑部病变(AMD)、白内障和干眼症等与眼睛相关的疾病的增加增加了对眼睛保健补充品的需求。随着世界人口老化的增加,这些疾病的盛行率预计将上升,为促进和维持最佳眼睛健康的补充品创造一个不断增长的市场。

全球眼保健补充品市场的限制因素

儘管有轶事证据和早期研究表明眼睛保健补充品具有积极作用,但有关其有效性和长期影响的整体科学证据有限。缺乏全面的临床研究和标准化调查方法是一个限制因素,可能会削弱消费者对补充品的信任和接受度。

全球眼保健补充品市场趋势

消费者对维持最佳眼睛健康和预防与老龄化,促使人们采取积极主动的措施。人们正在积极地将眼保健补充品纳入他们的整体健康习惯中。

消费者越来越喜欢由天然有机成分製成的眼保健补充品。重点是不含合成添加剂、防腐剂和人工色素的产品。这些趋势迫使製造商生产具有透明和清洁成分的补充品。

眼部保健补充品现在旨在解决特定的眼部疾病,例如老龄化黄斑部病变(AMD)、白内障、干眼症和青光眼。製造商根据消费者的具体偏好开发专门的配方,并满足与这些条件相关的独特营养需求。

含有维生素、矿物质、抗氧化剂和其他必需营养素的眼部保健补充品越来越受欢迎。这些补充品为整体眼睛健康提供全面支持,并为喜欢单一产品满足多种营养需求的消费者提供了便利的选择。

目录

  • 执行摘要
  • 调查方法
  • 母市场分析
  • 主要市场考察
    • 技术分析
    • 价格分析
    • 供应链分析
    • 价值链分析
    • 市场生态系统
    • 智慧财产权分析
    • 贸易分析
    • Start-Ups分析
    • 原料分析
    • 创新矩阵
    • 研发线产品分析
    • 总体经济指标
    • 主要投资分析
    • 关键成功因素
    • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
    • 监管形势
    • 波特的分析
    • 对未来中断的特殊考虑
  • 全球眼部保健补充品市场:依成分类型
    • 市场概况
    • 叶黄素和玉米黄质
    • 抗氧化剂
    • Omega-3脂肪酸
    • Coenzyme Q10
    • 类黄酮
    • 硫辛酸
    • 虾青素
    • 和其他补充品
  • 全球眼部保健补充品市场:依适应症分类
    • 市场概况
    • 老龄化黄斑部病变(AMD)
    • 白内障
    • 干眼症
    • 发炎
    • 其他的
  • 全球眼部保健补充品市场:按剂型
    • 市场概况
    • 锭剂
    • 胶囊
    • 粉末
    • 软凝胶
    • 液体
  • 全球眼保健补充品市场规模:依地区划分
    • 市场概况
    • 北美洲
      • 美国
      • 加拿大
    • 欧洲
      • 德国
      • 西班牙
      • 法国
      • 英国
      • 其他欧洲国家地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 拉丁美洲
      • 巴西
      • 其他拉丁美洲地区
    • 中东和非洲 (MEA)
      • 海湾合作委员会国家
      • 南非
      • 其他中东/非洲地区
  • 竞争形势
    • 前5名企业对比
    • 主要企业市场定位(2021年)
    • 主要市场参与者所采取的策略
    • 关键成功策略
    • 近期市集活动
    • 主要企业市场占有率(2021年)
  • 主要企业简介
    • Bausch Health Companies Inc.
    • Vitabiotics Ltd.
    • Novartis International AG
    • Alcon Inc.
    • The Nature's Bounty Co.
    • Pfizer Inc.
    • Amway Corporation
    • ZeaVision Holdings, Inc.
    • Valeant Pharmaceuticals International, Inc.
    • Swanson Health Products, Inc.
    • GNC Holdings Inc.
    • Nature's Way Products, LLC
    • EyePromise
    • The Himalaya Drug Company
    • Nutraceutical Corporation
    • Vitafusion
    • EyeScience Labs, LLC
    • NOW Foods
    • Ocuvite(Abbott Laboratories)
    • Carlson Labs
简介目录
Product Code: SQMIG35I2201

Global Eye Health Supplements Market size was valued at USD 1.79 Billion in 2022 and is poised to grow from USD 1.9 Billion in 2023 to USD 3.00 Billion by 2031, at a CAGR of 5.9% during the forecast period (2024-2031).

The market for eye health products is witnessing significant growth, propelled by various factors such as the increasing incidence of vision impairment and myopic vision, particularly during the COVID-19 pandemic due to heightened screen usage and online interactions while working from home. The surge in myopia is linked to a higher risk of developing progressive eye conditions like cataracts, glaucoma, and age-related macular degeneration. This trend has led to a heightened demand for eye health products among both elderly individuals and millennials, who are susceptible to digital eye fatigue and myopia, contributing to global market expansion. The prevalence of various eye conditions, including Age-related Macular Degeneration (AMD), dry eye syndrome, cataracts, and inflammation, along with endorsements from ophthalmologists for the use of eye health supplements in preventing and treating these disorders, is further driving market growth. The World Health Organization (WHO) reports that approximately 2.2 billion people worldwide suffer from vision impairment or blindness, with low and middle-income countries experiencing significantly higher rates than high-income countries. Women, especially in poorer nations, are more likely to be affected by eye diseases such as cataracts and AMD. In developed countries like the United States, Canada, Australia, and the United Kingdom, high per-capita expenditures on healthcare items, including eye health dietary supplements, are contributing to market expansion. The increasing demand for supplements containing Lutein & Zeaxanthin and bilberry extract for promoting eye wellness, coupled with easy accessibility through direct sales and e-commerce platforms, is further fueling market growth. Moreover, the market is expected to experience a boost with the introduction of new eye health supplements aimed at meeting the needs of the 1.0 billion untreated individuals with vision impairment worldwide. For instance, Bausch + Lomb launched its PreserVision AREDS 2 Formula micro gel eye vitamins in the United States in 2020, providing a more convenient option for individuals with advanced AMD compared to the company's previous soft gel formula. The robust sales channels and supply networks for these supplements also contribute significantly to market expansion. A NutraIngredients survey reveals a substantial increase in internet sales of eye health supplements, rising to approximately 48.3% in recent months, driven in part by the COVID-19 crisis. This emphasizes the resilience and adaptability of the market, paving the way for further growth in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Eye Health Supplements Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Eye Health Supplements Market Segmental Analysis

The global eye health supplements Market is segmented into ingredient type, indication, formulation and region. Based on ingredient type, the market is segmented into lutein and zeaxanthin, antioxidants, omega-3 fatty acids, coenzyme Q10, flavonoids, alpha-lipoic acid, astaxanthin, and other supplements. Based on indication, the market is segmented into age-related macular degeneration (AMD), cataract, dry eye syndrome, inflammation, and others. Based on formulation, the market is segmented into tablets, capsules, powder, softgels, liquid. Based on region, the global Eye Health Supplements Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Eye Health Supplements Market

The increasing occurrence of eye-related conditions like age-related macular degeneration (AMD), cataracts, and dry eye syndrome is fueling the need for eye health supplements. With a rising global aging population, the prevalence of these disorders is anticipated to climb, generating an expanding market for supplements designed to promote and maintain optimal eye health.

Restraints in the Global Eye Health Supplements Market

Although there is anecdotal evidence and initial studies suggesting the positive effects of eye health supplements, the overall scientific evidence regarding their effectiveness and long-term impact is constrained. The absence of comprehensive clinical studies and standardized research methodologies serves as a limitation, potentially undermining consumer confidence and acceptance of these supplements.

Market Trends of the Global Eye Health Supplements Market

A rising awareness among consumers regarding the significance of maintaining optimal eye health and preventing age-related eye conditions is prompting a proactive approach. Individuals are actively incorporating eye health supplements into their overall wellness routines.

Consumers are showing a growing preference for eye health supplements crafted from natural and organic ingredients. The emphasis is on products devoid of synthetic additives, preservatives, and artificial colors. This inclination is compelling manufacturers to create supplements with transparent and clean ingredient profiles.

Eye health supplements are now being designed to address particular eye conditions like age-related macular degeneration (AMD), cataracts, dry eye syndrome, and glaucoma. Manufacturers are developing specialized formulations tailored to meet the unique nutritional requirements associated with these conditions, aligning with the specific preferences of consumers.

Combination eye health supplements, encompassing a blend of vitamins, minerals, antioxidants, and other essential nutrients, are gaining traction. These supplements provide comprehensive support for overall eye health, offering a convenient option for consumers who prefer a single product addressing multiple nutritional needs.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
    • Regulatory Landscape
    • Porters Analysis
      • Competitive rivalry
      • Threat of Substitute Products
      • Bargaining Power of Buyers
      • Threat of New Entrants
      • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
      • Political Impact
      • Economic Impact
      • Social Impact
      • Technical Impact
      • Environmental Impact
      • Legal Impact
  • Global Eye Health Supplements Market by Ingredient Type
    • Market Overview
    • Lutein and Zeaxanthin
    • Antioxidants
    • Omega-3 Fatty acids
    • Coenzyme Q10
    • Flavonoids
    • Alpha-Lipoic Acid
    • Astaxanthin
    • and Other Supplements
  • Global Eye Health Supplements Market by Indication
    • Market Overview
    • Age-related Macular Degeneration (AMD)
    • Cataract
    • Dry Eye Syndrome
    • Inflammation
    • and Others
  • Global Eye Health Supplements Market by Formulation
    • Market Overview
    • Tablets
    • Capsules
    • Powder
    • Softgels
    • Liquid
  • Global Eye Health Supplements Market Size by Region
    • Market Overview
    • North America
      • USA
      • Canada
    • Europe
      • Germany
      • Spain
      • France
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC Countries
      • South Africa
      • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
      • By Development
      • By Company
      • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Bausch Health Companies Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Vitabiotics Ltd.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Novartis International AG
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Alcon Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • The Nature's Bounty Co.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Pfizer Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Amway Corporation
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • ZeaVision Holdings, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Valeant Pharmaceuticals International, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Swanson Health Products, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • GNC Holdings Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Nature's Way Products, LLC
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • EyePromise
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • The Himalaya Drug Company
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Nutraceutical Corporation
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Vitafusion
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • EyeScience Labs, LLC
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • NOW Foods
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Ocuvite (Abbott Laboratories)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Carlson Labs
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments